GeneReach Biotechnology Corp. (TPEX:4171)
Taiwan · Delayed Price · Currency is TWD 17.30
-0.10 (-0.57%)
Jun 18, 2026, 1:30 PM CST
GeneReach Biotechnology Market Cap
GeneReach Biotechnology has a market cap or net worth of 991.34 million as of June 18, 2026. Its market cap has decreased by -21.58% in one year.
Market Cap
991.34M
Enterprise Value
925.37M
Revenue
232.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
17.30
Market Cap Chart
Since November 19, 2012, GeneReach Biotechnology's market cap has decreased from 1.27B to 991.34M, a decrease of -22.10%. That is a compound annual growth rate of -1.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 991.34M | -8.62% |
| Dec 31, 2025 | 1.08B | -34.10% |
| Dec 31, 2024 | 1.65B | -27.38% |
| Dec 29, 2023 | 2.27B | -25.28% |
| Dec 30, 2022 | 3.03B | -20.04% |
| Dec 30, 2021 | 3.79B | -27.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Enimmune | 1.17B |
| BiOptic | 1.13B |
| LabTurbo Biotech | 1.09B |
| Holy Stone Healthcare | 1.06B |
| Level Biotechnology | 1.01B |
| Lukas Biomedical | 986.14M |
| TCI GENE | 978.96M |
| U-Neuron Biomedical | 955.94M |